The Business Times
SUBSCRIBERS

Hong Kong seeks to cash in on frenzy for Chinese biotech stocks

HK bourse is in the midst of weighing a proposal that would allow biotech firms to list before they turn a profit

Published Mon, Jan 29, 2018 · 09:50 PM
Share this article.

Hong Kong

CHINESE drug companies have been on a tear in the US stock market. Now, entrepreneurs and investors betting on the Asian country's fledgling biotechnology industry see another reason for optimism.

The stock exchange in Hong Kong - home to the world's fourth-largest equity market - is in the midst of weighing a proposal that would allow biotech companies to list even before they turn a profit.

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here